ALEC Alector, Inc. Earnings per share growth rate in current year
YoY EPS changes demonstrate profitability dynamics, where the parameter value reaches 133.90. Alector, Inc. (ALEC) is shielded from market pressure through alliances with industry behemoths prior to the start of sales. Synergy with global holdings accelerates the search for methods to combat Alzheimer's disease, while automated molecule selection is supplemented by expert physician oversight during clinical trials.
Analytical breakdowns and data insights for company alector.com (ALEC)
- share price and expert price forecast:
- market capitalization data:
- balance sheet equity data:
- debt and liquidity details:
- net income and valuation multiples indicators:
ALEC - Company Net Income|Expected Profit Alector, Inc.|ALEC - P/E Multiple|Projected Price to Earnings Ratio Alector|ALEC - PEG Multiple|Enterprise Value to EBITDA Ratio Alector, Inc.|ALEC - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Alector|ALEC - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months alector.com|ALEC - Net earnings per share growth this year|Earnings growth forecast for next year Alector, Inc.
Fundamental valuation:ALEC, Alector Therapeutics
Fundamental asset screening requires a precise determination of the trend reversal point through an analysis of net income dynamics. Year-over-year EPS growth measures the percentage change in earnings per share, signaling a business revaluation, which is critical for Alector, Inc. (ALEC) given the external co-financing of Alzheimer's disease research and the maintenance of liquidity.
Key competitors
BIIB: Net earnings per one share growth for the current year|Earnings per share growth in current year Neurocrine Biosciences Inc|Earnings per share growth rate in current year Regencell Corp RGC|Earnings per share growth in current year Axsome Therapeutics (AXSM)|ACAD (acadia-pharm.com) - Earnings per share increase in current year|Xenon - Net earnings per share growth this year|Earnings per share increase in current year VKTX|Supernus Pharma - Earnings growth in current year|Expected net earnings per share growth this year Catalyst Corp CPRX|Denali Therapeutics (DNLI) - Earnings per share growth in current year|Earnings per share growth this year HRMY|BHVN (Biohaven) - Earnings growth in current year|Net earnings per share growth this year Amylyx Pharmaceuticals Inc (AMLX)|Net earnings per share growth this year TRVI (Trevi Pharma)|Expected net earnings per share growth this year Praxis Corp|Earnings growth in current year AVXL (Anavex Life Sciences)|Earnings growth in current year ceribell.com CBLL|PRTA - Earnings per share growth in current year|ANNX: Earnings per share growth in current year|OMER: Earnings growth in current year|Earnings per share growth rate in current year Neurogene Therapeutics (NGNE)|ACIU (AC Immune) - Earnings growth in current year|Net earnings per share growth this year voyagertherapeutics.com (VYGR)|Earnings per share growth in current year Neumora Therapeutics, Inc. (NMRA)|Scilex Holding - Earnings per share growth this year|Earnings growth in current year TVGN (Tevogen Bio Holdings, Inc.)|Alpha Cognition Inc (ACOG) - Earnings per share growth rate in current year|CGTX: Net earnings per share growth this year|IKT - Earnings growth in current year|Cassava Sciences (SAVA) - Earnings per share growth in current year|Assertio - Earnings per share increase in current year|Earnings per share growth in current year Coya Therapeutics Inc|Earnings per share growth rate in current year VistaGen Therapeutics Inc VTGN|Earnings growth in current year OVID|Earnings growth in current year acumenpharm.com (ABOS)|Earnings per share growth in current year CervoMed CRVO|Alterity Therapeutics Ltd. - Earnings per share growth in current year|Clene Nanomedicine - Earnings growth in current year|Earnings per share growth rate in current year PepGen Inc.|JUNS: Earnings growth in current year|Net earnings per share growth this year relmada.com|Net earnings per share growth this year ANVS|GRCE (Grace Tx) - Net earnings per one share growth for the current year|Earnings per share growth in current year Firefly Neuroscience Inc (AIFF)|KLTO - Earnings per share growth rate in current year|Earnings per share growth in current year NeuroSense Therapeutics Ltd. NRSN|Earnings per share increase in current year RVPH|MTVA: Net earnings per share growth this year|Earnings per share increase in current year NRXS (NeurAxis Inc.)|HSDT: Earnings growth in current year|PASG - Expected net earnings per share growth this year|Earnings per share growth in current year Neuphoria Therapeutics, Inc.|Earnings per share growth this year NERV (minervaneurosciences.com)|Earnings growth in current year ATHA|Net earnings per share growth this year Addex Therapeutics Ltd. ADXN|Alzamend Neuro - Net earnings per share growth this year|Expected net earnings per share growth this year Cyclerion Therapeutics Inc. (CYCN)|Protagenic - Earnings growth in current year|KTTA - Earnings growth in current year|cortigent.com (CRGT) - Earnings per share growth in current year|ATXI (Avenue Therapeutics Inc.) - Earnings per share growth in current year|BCLI (Brainstorm Cell Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Cara Therapeutics Inc CARA|Earnings growth in current year CHRO|Net earnings per share growth this year eliemtx.com ELYM|Earnings per share growth in current year Intra-Cellular Therapies, Inc. ITCI|LBPH: Earnings per share growth this year|Marinus - Earnings growth in current year|Earnings per share growth rate in current year NKGen Biotech Corp|NRBO (NeuroBo Pharmaceuticals) - Net earnings per share growth this year|sagerx.com (SAGE) - Earnings growth in current year|Earnings per share growth in current year Synaptogenix|TRVN: Earnings per share increase in current year|Earnings per share growth in current year Vigil Neuroscience (VIGL)|WENA - Earnings per share growth rate in current year|Earnings growth in current year CERE (Cerevel Therapeutics)
